Nutraceutix
This article was originally published in The Tan Sheet
Executive Summary
Ingredient supplier reports year-end estimated net earnings of $200,000 compared to $584,217 loss in 1999, although sales dipped 13.6% to $8.9 mil. Fourth quarter sales increased 7% to $2.7 mil.; earnings of approximately $100,000 recorded compared to $550,626 loss in 4Q 1999. Redmond, Wash.-based company cites second quarter cost reductions and gross margin strengthening for bottom line improvement. Calcium D-glucarate sales of $1.2 mil. in 2000 represent a 6.2% increase. Firm also announces introduction of Low Osmolality sports drink and Controlled Delivery Technology Ma huang ingredient available in six- and 12-hour release profiles
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning